Login Register Cart 0
Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives

Author(s): Camila Capelini, Vitória R.F. Câmara, José D. Figueroa Villar, Juliana M.C. Barbosa, Kelly Salomão, Solange L. de Castro, Policarpo A.S. Junior, Silvane M.F. Murta, Thais B. Couto, Maria C.S. Lourenço, James L. Wardell, John N. Low, Edson F. da Silva and Samir A. Carvalho*

Volume 17, Issue 6, 2021

Published on: 21 January, 2020

Page: [630 - 637] Pages: 8

DOI: 10.2174/1573406416666200121105215

Price: $65

Abstract

Background: Near to 5-7 million people are infected with T. cruzi in the world, and about 10,000 people per year die of problems associated with this disease.

Methods: Herein, the synthesis, antitrypanosomal and antimycobacterial activities of seventeen coumarinic N-acylhydrazonic derivatives have been reported.

Results: These compounds were synthesized using methodology with reactions global yields ranging from 46%-70%. T. cruzi in vitro effects were evaluated against trypomastigote and amastigote, forming M. tuberculosis activity towards H37Rv sensitive strain and resistant strains.

Discussion: Against T. cruzi, the more active compounds revealed only moderate activity IC50/96h~20 μM for both trypomastigotes and amastigotes intracellular forms. (E)-2-oxo-N'- (3,4,5-trimethoxybenzylidene)-2H-chromene-3-carbohydrazide showed meaningful activity in INH resistant/RIP resistant strain.

Conclusion: These compound acting as multitarget could be good leads for the development of new trypanocidal and bactericidal agents.

Keywords: Antitrypanosomal, antimycobacterial, coumarine, N-Acylhydrazone, chagas, tuberculosis.

« Previous Next »
Graphical Abstract

[1]
Dumonteil, E.; Herrera, C. Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges. PLoS Negl. Trop. Dis., 2017, 11(4), e0005422.
[http://dx.doi.org/10.1371/journal.pntd.0005422] [PMID: 28426735]
[2]
Salomão, K.; Menna-Barreto, R.F.S.; de Castro, S.L. Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy. Curr. Top. Med. Chem., 2016, 16(20), 2266-2289.
[http://dx.doi.org/10.2174/1568026616666160413125049] [PMID: 27072716]
[3]
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis Enzyme Targets and their Inhibitors. Curr. Top. Med. Chem., 2019, 19(5), 337-355.
[http://dx.doi.org/10.2174/1568026619666190219105722] [PMID: 30806318]
[4]
de Souza, M.V.N. Promising drugs against tuberculosis. Recent Pat. Antiinfect. Drug Discov., 2006, 1(1), 33-44.
[http://dx.doi.org/10.2174/157489106775244163] [PMID: 18221132]
[5]
Peermohammed, S.Z.; Balkrishna, B.S. Drugs in treatment of tuberculosis: A review. Int. J. Univ. Pharm. Bio Sci., 2017, 6, 28-84.
[6]
Duarte, C.D.; Barreiro, E.J.; Fraga, C.A.M. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev. Med. Chem., 2007, 7(11), 1108-1119.
[http://dx.doi.org/10.2174/138955707782331722] [PMID: 18045214]
[7]
Fraga, C.A.M.; Barreiro, E.J. Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Curr. Med. Chem., 2006, 13(2), 167-198.
[http://dx.doi.org/10.2174/092986706775197881] [PMID: 16472212]
[8]
Li, R.; Chen, X.; Gong, B.; Selzer, P.M.; Li, Z.; Davidson, E.; Kurzban, G.; Miller, R.E.; Nuzum, E.O.; McKerrow, J.H.; Fletterick, R.J.; Gillmor, S.A.; Craik, C.S.; Kuntz, I.D.; Cohen, F.E.; Kenyon, G.L. Structure-based design of parasitic protease inhibitors. Bioorg. Med. Chem., 1996, 4(9), 1421-1427.
[http://dx.doi.org/10.1016/0968-0896(96)00136-8] [PMID: 8894100]
[9]
Rodrigues, C.R.; Flaherty, T.M.; Springer, C.; McKerrow, J.H.; Cohen, F.E. CoMFA and HQSAR of acylhydrazide cruzain inhibitors. Bioorg. Med. Chem. Lett., 2002, 12(11), 1537-1541.
[http://dx.doi.org/10.1016/S0960-894X(02)00189-0] [PMID: 12031337]
[10]
Ifa, D.; Rodrigues, C.R.; de Alencastro, R.B.; Fraga, C.A.M.; Barreiro, E.J. A Possible Molecular Mechanism for the Inhibition of Cysteine Proteases by Salicylaldehyde N-Acylhydrazones and Related Compounds. J. Mol. Struct. THEOCHEM, 2000, 505, 11-17.
[http://dx.doi.org/10.1016/S0166-1280(99)00307-3]
[11]
Belluti, F.; Uliassi, E.; Veronesi, G.; Bergamini, C.; Kaiser, M.; Brun, R.; Viola, A.; Fato, R.; Michels, P.A.M.; Krauth-Siegel, R.L.; Cavalli, A.; Bolognesi, M.L. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi. ChemMedChem, 2014, 9(2), 371-382.
[http://dx.doi.org/10.1002/cmdc.201300399] [PMID: 24403089]
[12]
Vazquez-Rodriguez, S.; Guíñez, R.F.; Matos, M.J.; Olea-Azar, C.; Maya, J.D.; Uriarte, E.; Santana, L. Facing Chagas’ disease: trypanocidal properties of new coumarin-chalcone scaffolds. Med. Chem., 2016, 12, 537-543.
[http://dx.doi.org/10.2174/1573406412666160107111809] [PMID: 26740208]
[13]
Angelova, V.T.; Valcheva, V.; Vassilev, N.G.; Buyukliev, R.; Momekov, G.; Dimitrov, I.; Saso, L.; Djukic, M.; Shivachev, B. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold. Bioorg. Med. Chem. Lett., 2017, 27(2), 223-227.
[http://dx.doi.org/10.1016/j.bmcl.2016.11.071] [PMID: 27914798]
[14]
Cardoso, S.H.; Barreto, M.B.; Lourenço, M.C.S.; Henriques, Md.; Candéa, A.L.P.; Kaiser, C.R.; de Souza, M.V.N. Antitubercular activity of new coumarins. Chem. Biol. Drug Des., 2011, 77(6), 489-493.
[http://dx.doi.org/10.1111/j.1747-0285.2011.01120.x] [PMID: 21414146]
[15]
Carvalho, S.A.; da Silva, E.F.; Santa-Rita, R.M.; de Castro, S.L.; Fraga, C.A.M. Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues. Bioorg. Med. Chem. Lett., 2004, 14(24), 5967-5970.
[http://dx.doi.org/10.1016/j.bmcl.2004.10.007] [PMID: 15546709]
[16]
Carvalho, S.A.; Harrison, W.T.A.; Fraga, C.A.M.; da Silva, E.F.; Wardell, J.L.; Wardell, S.M.S.V. 5-Phenyl-2-(Benzalhydrazonyl)-1,3,4-Thiadiazoles, Potential Trypanocidal Agents: Consistent Dimer Formation via N–H • • • N Intermolecular Hydrogen Bonds. Zeitschrift für Krist., 2009, 224, 598-606.
[http://dx.doi.org/10.1524/zkri.2009.1203]
[17]
Carvalho, S.A.; da Silva, E.F.; Lourenco, M.C.S.; de Souza, M.V.N.; Fraga, C.A.M. Antimycobacterial Profile of 5-Phenyl-1,3,4-Thiadiazole-2-Arylhydrazone Derivatives. Lett. Drug Des. Discov., 2010, 7, 606-609.
[http://dx.doi.org/10.2174/157018010792062768]
[18]
Pinheiro, A.C.; Kaiser, C.R.; Nogueira, T.C.M.; Carvalho, S.A.; da Silva, E.F. Feitosa, Lde.O.; Henriques, Md.; Candéa, A.L.P.; Lourenço, M.C.S.; de Souza, M.V.N. Synthesis and antitubercular activity of new L-serinyl hydrazone derivatives. Med. Chem., 2011, 7(6), 611-623.
[http://dx.doi.org/10.2174/157340611797928325] [PMID: 22313301]
[19]
Carvalho, S.A.; Feitosa, L.O.; Soares, M.; Costa, T.E.M.M.; Henriques, M.G.; Salomão, K.; de Castro, S.L.; Kaiser, M.; Brun, R.; Wardell, J.L.; Wardell, S.M.; Trossini, G.H.; Andricopulo, A.D.; da Silva, E.F.; Fraga, C.A. Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents. Eur. J. Med. Chem., 2012, 54, 512-521.
[http://dx.doi.org/10.1016/j.ejmech.2012.05.041] [PMID: 22727447]
[20]
Messeder, J.C.; Tinoco, L.W.; Figueroa-Villar, J.D.; Souza, E.M.; Santa Rita, R.; de Castro, S.L. Aromatic Guanyl Hydrazones: Synthesis, Structural Studies and in Vitro Activity Against Trypanosma cruzi. Bioorg. Med. Chem. Lett., 1995, 5, 3079-3084.
[http://dx.doi.org/10.1016/0960-894X(95)00541-5]
[21]
Romanha, A.J.; Castro, S.L. Soeiro, Mde.N.; Lannes-Vieira, J.; Ribeiro, I.; Talvani, A.; Bourdin, B.; Blum, B.; Olivieri, B.; Zani, C.; Spadafora, C.; Chiari, E.; Chatelain, E.; Chaves, G.; Calzada, J.E.; Bustamante, J.M.; Freitas-Junior, L.H.; Romero, L.I.; Bahia, M.T.; Lotrowska, M.; Soares, M.; Andrade, S.G.; Armstrong, T.; Degrave, W.; Andrade, Zde.A. in vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz, 2010, 105(2), 233-238.
[http://dx.doi.org/10.1590/S0074-02762010000200022] [PMID: 20428688]
[22]
Franzblau, S.G.; Witzig, R.S.; McLaughlin, J.C.; Torres, P.; Madico, G.; Hernandez, A.; Degnan, M.T.; Cook, M.B.; Quenzer, V.K.; Ferguson, R.M.; Gilman, R.H. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol., 1998, 36(2), 362-366.
[PMID: 9466742]
[23]
Data for compound 15 were obtained at 100(2) K with CuKa, l = 1.54178 Å radiation by means of the Rigaku diffractometer. Data collection, data reduction and unit cell refinement were carried out under the control of the program CrysAlis PRO 1.171.38.41.,
[24]
MERCURY 3.9. Cambridge Crystallographic Data Centre, UK, 2018; Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. 2008, 6, 112-122; Spek, A.L. Acta Crystallogr. 2009, D65, 148; McArdle, P.; Gilligan, K.; Cunningham, D.; Dark,R.; Mahon, M. Cryst. Eng. Comm. 2004, 6, 303. Sheldrick, G.M. Acta Crystallogr. 2015, A71, 3. Hübschle, C. B.; Sheldrick, G. M.; Dittrich, B. J. Appl. Crystallogr. 2011, 1281. Sheldrick, G. M. Acta Crystallogr., 2015, C71, 3.
[25]
http://www.ccdc.cam.ac.uk
[26]
Morgan, E. Vogel’s Textbook of Practical Organic Chemistry, 1990, 14, p. 148.
[27]
Zhang, X.; Breslav, M.; Grimm, J.; Guan, K.; Huang, A.; Liu, F.; Maryanoff, C.A.; Palmer, D.; Patel, M.; Qian, Y.; Shaw, C.; Sorgi, K.; Stefanick, S.; Xu, D. A new procedure for preparation of carboxylic acid hydrazides. J. Org. Chem., 2002, 67(26), 9471-9474.
[http://dx.doi.org/10.1021/jo026288n] [PMID: 12492358]
[28]
Lima, P.C.; Lima, L.M.; da Silva, K.C.M.; Léda, P.H.O.; de Miranda, A.L.P.; Fraga, C.A.M.; Barreiro, E.J. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur. J. Med. Chem., 2000, 35(2), 187-203.
[http://dx.doi.org/10.1016/S0223-5234(00)00120-3] [PMID: 10758281]
[29]
Glidewell, C.; Low, J.N.; Wardell, J.L. 2-Nitrobenzaldehyde 2-Iodobenzoylhydrazone. Acta Crystallogr. Sect. E Struct. Rep. Online, 2005, 61, o2438-o2440.
[http://dx.doi.org/10.1107/S1600536805021355]
[30]
Palla, G.; Predieri, G.; Domiano, P.; Vignali, C.; Turner, W. Conformational Behaviour and E/Z Isomerization of N-Acyl and N-Aroylhydrazones. Tetrahedron, 1986, 42, 3649-3654.
[http://dx.doi.org/10.1016/S0040-4020(01)87332-4]
[31]
De Souza, A.A.N.; Xavier, V.F.; Coelho, G.S.; Sales, P.A. Junior; Romanha, A.J.; Murta, S.M.F.; Carneiro, C.M.; Taylor, J.G. Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity. Artic. J. Braz. Chem. Soc., 2018, 29, 269-277.
[32]
Elias, P.R.; Coelho, G.S.; Xavier, V.F.; Sales, Junior, P.A.; Romanha, A.J.; Murta, S.M.F.; Carneiro, C.M.; Camilo, N.S.; Hilário, F.F.; Taylor, J.G. Synthesis of Xylitan Derivatives and Preliminary Evaluation of in vitro Trypanocidal Activity. Molecules, 2016, 21(10), 1342.
[http://dx.doi.org/10.3390/molecules21101342] [PMID: 27735872]

Rights & Permissions Print Cite
Article Metrics
48
3
© 2024 Bentham Science Publishers | Privacy Policy